Artwork

Indhold leveret af MediCom Oncology. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af MediCom Oncology eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Player FM - Podcast-app
Gå offline med appen Player FM !

How does the safety profile of the new and emerging anti-PD 1 antibodies differ from chemotherapy?

1:55
 
Del
 

Manage episode 182688939 series 1375096
Indhold leveret af MediCom Oncology. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af MediCom Oncology eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Listen as Dr. Alison Moskowitz discusses the safety profile of the new and emerging anti-PD1 antibodies and how this differs from traditional chemotherapy in just under two minutes.
  continue reading

53 episoder

Artwork
iconDel
 
Manage episode 182688939 series 1375096
Indhold leveret af MediCom Oncology. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af MediCom Oncology eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Listen as Dr. Alison Moskowitz discusses the safety profile of the new and emerging anti-PD1 antibodies and how this differs from traditional chemotherapy in just under two minutes.
  continue reading

53 episoder

Alle episoder

×
 
Loading …

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Hurtig referencevejledning